Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Goetz

Showing results (211-220 of 313) with videos related to

Pageof 32
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2009
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's diseaseMarian L Evatt, K Ray Chaudhuri, Kelvin L Chou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseFrançois Tison, Charlotte Keywood, Mark Wakefield, et al.
American Journal of Medical Genetics. Part A|December 8, 2006
Neuropathic features in fragile X premutation carriersElizabeth Berry-Kravis, Christopher G Goetz, Maureen A Leehey, et al.
Nature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendationsChristopher G Goetz, Werner Poewe, Olivier Rascol, et al.
Annals of Neurology|January 26, 2005
A responsive outcome for Parkinson's disease neuroprotection futility studiesJordan J Elm, Christopher G Goetz, Bernard Ravina, et al.
Frontiers in Aging Neuroscience|June 1, 2022
Parkinson's Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing PlanMichelle H S Tosin, Christopher G Goetz, Dharah P C F Bispo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2007
Depression rating scales in Parkinson's disease: critique and recommendationsAnette Schrag, Paolo Barone, Richard G Brown, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 23, 2018
Telemedicine Use for Movement Disorders: A Global SurveyAnhar Hassan, E Ray Dorsey, Christopher G Goetz, et al.
Pageof 32

Showing results (211-220 of 313) with videos related to

Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2009
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's diseaseMarian L Evatt, K Ray Chaudhuri, Kelvin L Chou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseFrançois Tison, Charlotte Keywood, Mark Wakefield, et al.
American Journal of Medical Genetics. Part A|December 8, 2006
Neuropathic features in fragile X premutation carriersElizabeth Berry-Kravis, Christopher G Goetz, Maureen A Leehey, et al.
Nature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendationsChristopher G Goetz, Werner Poewe, Olivier Rascol, et al.
Annals of Neurology|January 26, 2005
A responsive outcome for Parkinson's disease neuroprotection futility studiesJordan J Elm, Christopher G Goetz, Bernard Ravina, et al.
Frontiers in Aging Neuroscience|June 1, 2022
Parkinson's Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing PlanMichelle H S Tosin, Christopher G Goetz, Dharah P C F Bispo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2007
Depression rating scales in Parkinson's disease: critique and recommendationsAnette Schrag, Paolo Barone, Richard G Brown, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 23, 2018
Telemedicine Use for Movement Disorders: A Global SurveyAnhar Hassan, E Ray Dorsey, Christopher G Goetz, et al.
Pageof 32